中科電氣(300035.SZ):2019年淨利預增5%-30%
格隆匯1月20日丨中科電氣(300035.SZ)披露2019年度業績預告,公司預計2019年1-12月歸屬於上市公司股東的淨利潤為約1.37億元-約1.69億元,同比增長5%-30%。業績變動原因如下:
1、本年度業績增長的主要原因是公司鋰電負極業務產能釋放,銷量提升,收入增加。
2、預計2019年非經常性損益對淨利潤的影響金額約為716萬元,2019年非經常性損益對淨利潤的影響較2018年要小,預計2019年歸屬於上市公司股東的扣除非經常性損益的淨利潤比上年度增長41%-76%。
3、2019年為公司股權激勵計劃實施的第一年,攤銷了股權激勵相關費用2196.67萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.